• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Merit Medical Systems Inc.

    8/29/24 4:07:02 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care
    Get the next $MMSI alert in real time by email
    S-8 1 mmsi-20240829xs8.htm S-8

    As filed with the Securities and Exchange Commission on August 29, 2024

    Registration No. 333-

    ​

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    ​

    ​

    ​

    ​

    ​

    FORM S-8

    REGISTRATION STATEMENT

    Under the

    Securities Act of 1933

    ​

    ​

    ​

    MERIT MEDICAL SYSTEMS, INC.

    (Exact name of registrant as specified in its charter)

    ​

    Utah

    (State or other jurisdiction of

    incorporation or organization)

    87-0447695

    (I.R.S. Employer

    Identification No.)

    ​

    ​

    ​

    1600 West Merit Parkway

    South Jordan, Utah 84095

    Telephone: (801) 253-1600

    (Address of Principal Executive Offices,

    including Zip Code)

    ​

    Merit Medical Systems, Inc.

    2018 Long-Term Incentive Plan

    (Full title of the plan)

    ​

    and Corporate Secretary

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    Brian G. Lloyd

    Chief Legal Officer and Corporate Secretary

    Merit Medical Systems, Inc.

    1600 West Merit Parkway

    South Jordan, Utah 84095

    (801) 253-1600

    (Name, address and telephone number, including area code, of agent for service)

    Copy to:

    ​

    Dane Johansen

    Parr Brown Gee & Loveless

    101 South 200 East, Suite 700

    Salt Lake City, Utah 84111

    (801) 532-7840

    ​

    ​

    ​

    ​

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

    ​

    Large accelerated filer þ

    ​

    Accelerated filer ◻

    Non-accelerated filer ◻

    (Do not check if a smaller reporting company)

    Smaller reporting company ◻

    ​

    Emerging growth company ◻

    ​

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ◻

    ​

    ​


    ​

    EXPLANATORY NOTE

    ​

    This Registration Statement on Form S-8 is filed pursuant to General Instruction E to Form S-8 for the purpose of registering an additional 3,000,000 shares of the common stock, no par value, (the “Common Stock”), of Merit Medical Systems, Inc. (the “Registrant”) issuable under the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan, as amended (the “Incentive Plan”). The Registrant’s shareholders approved the addition of these shares to the Incentive Plan at the Registrant’s Annual Meeting of Shareholders held on May 15, 2024.

    ​

    Pursuant to General Instruction E to Form S-8, this Registration Statement incorporates by reference the contents of the Registrant’s previously filed Registration Statement on Form S-8, File No. 333-225426, filed with the Securities and Exchange Commission (the “Commission”) on June 4, 2018 relating to the Incentive Plan, to the extent not otherwise amended or superseded by the contents hereof. In accordance with the instructional note to Part I of Form S-8 as promulgated by the Commission, the information specified by Part I of Form S-8 has been omitted from this Registration Statement.

    ​

    ​

    PART II

    ​

    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

    ​

    Item 3.Incorporation of Documents by Reference.

    ​

    The following documents filed by the Registrant with the Commission are hereby incorporated herein by reference:

    ​

    (1)The Registrant’s Annual Report on Form 10-K for the year ended December 31, 2023 filed with the Commission on February 28, 2024 (our “2023 Annual Report”);

    ​

    (2)The Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2024, filed with the Commission on April 30, 2024;

    ​

    (3)The Registrant’s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2024, filed with the Commission on August 1, 2024;

    ​

    (4)The Registrant’s Current Reports on Form 8-K, other than with respect to Items 2.02 or 7.01, filed with the Commission on January 8, 2024, February 28, 2024, April 30, 2024, May 16, 2024, May 21, 2024, July 1, 2024 and August 1, 2024;

    ​

    (5)The Registrant’s Definitive Proxy Statement on Schedule 14A for the annual meeting of shareholders held on May 15, 2024, filed with the Commission on April 2, 2024; and

    ​

    (6)The description of the Common Stock contained in the Registrant’s Registration Statement on Form 8-A filed with the Commission on May 11, 1990, including any amendment or report filed for the purpose of updating such description.

    ​

    In addition, all documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), other than documents or information deemed to have been furnished and not filed in accordance with SEC rules, prior to the filing of a post-effective amendment that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of filing of such documents. Any statement contained in a document incorporated by reference herein shall be deemed to be modified or superseded for purposes hereof to the extent that a statement contained herein (or in any other subsequently filed document which is also incorporated by reference herein) modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed to constitute a part hereof except as so modified or superseded.

    ​

    Under no circumstances will any information furnished under Items 2.02 or 7.01 of Form 8-K be deemed incorporated herein by reference unless such Form 8-K expressly provides to the contrary.


    ​

    Item 8. Exhibits.

    ​

    ​

    ​

    ​

    ​

    Exhibit
    Number

    Description

    ​

    Filing Status

    5.1

    ​

    Opinion of Parr Brown Gee & Loveless PC

    Filed herewith

    104.1

    ​

    Merit Medical Systems, Inc., 2018 Long-Term Incentive Plan (included as Exhibit 4.2 to the Registrant’s registration statement on Form S-8 filed with the Commission on June 4, 2018)

    Form S-8, filed June 4, 2018 (Exhibit No. 4.2)

    104.2

    ​

    Third Amendment to the Merit Medical Systems, Inc. 2018 Long-Term Incentive Plan (included as Appendix B to the Registrant’s Definitive Proxy Statement for its 2024 Annual Meeting of Stockholders filed with the Commission on April 2, 2024

    Schedule 14A, filed April 2, 2024 (Appendix B)

    23.1

    ​

    Consent of Deloitte & Touche LLP

    Filed herewith

    23.2

    ​

    Consent of Parr Brown Gee & Loveless

    Included in Exhibit 5.1, which is filed herewith

    24.1

    ​

    Power of Attorney

    Included in signature pages hereto

    107

    ​

    Calculation of filing fee tables

    Filed herewith

    ​

    ​

    ​


    SIGNATURES

    ​

    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in South Jordan, State of Utah, on August 29, 2024.

    ​

    ​

    ​

    ​

    MERIT MEDICAL SYSTEMS, INC.

    ​

    ​

    ​

    /s/ FRED P. LAMPROPOULOS

    Fred P. Lampropoulos

    Chairman of the Board and Chief Executive Officer

    ​

    POWER OF ATTORNEY

    ​

    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature to this registration statement appears below hereby constitutes and appoints Fred P. Lampropoulos (Chief Executive Officer), Raul Parra (Chief Financial Officer and Treasurer) and Brian G. Lloyd (Chief Legal Officer and Corporate Secretary), and each of them acting individually, as his or her true and lawful attorney-in-fact and agent, with full power of substitution, to sign on his or her behalf individually and in the capacity stated below and to perform any acts necessary to be done in order to file all amendments (including any post-effective amendments) to this registration statement, and any and all instruments or documents filed as part of or in connection with this registration statement or the amendments thereto, and to file the same with the Securities and Exchange Commission, granting unto say attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in or about the premises, as fully to all intents and purposes as he or she might or could do in person, and each of the undersigned does hereby ratify and confirm all that such attorneys-in-fact and agents, or any of them or their respective substitutes, may lawfully do or cause to be done by virtue hereof.

    ​

    Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated on August 29, 2024.

    ​

    ​

    ​

    ​

    Signature

    ​

    Capacity in Which Signed

    ​

    ​

    ​

    /s/ FRED P. LAMPROPOULOS

    ​

    Chief Executive Officer and Director

    Fred P. Lampropoulos

    ​

    (Principal executive officer)

    ​

    ​

    ​

    /s/ RAUL PARRA

    ​

    Chief Financial Officer and Treasurer

    Raul Parra

    ​

    (Principal financial and accounting officer)

    ​

    ​

    ​

    /s/ LONNY J. CARPENTER

    ​

    Director

    Lonny J. Carpenter

    ​

    ​

    ​

    ​

    ​

    ​

    /s/ STEPHEN C. EVANS

    ​

    Director

    Stephen C. Evans

    ​

    ​

    ​

    ​

    ​

    /s/ DAVID K. FLOYD

    ​

    Director

    David K. Floyd

    ​

    ​

    ​

    ​

    ​

    /s/ THOMAS J. GUNDERSON

    ​

    Director

    Thomas J. Gunderson

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​

    ​


    ​

    ​

    ​

    Signature

    ​

    Capacity in Which Signed

    ​

    ​

    ​

    /s/ LAURA S. KAISER

    ​

    Director

    Laura S. Kaiser

    ​

    ​

    ​

    ​

    ​

    /s/ MICHAEL R. MCDONNELL

    ​

    Director

    Michael R. McDonnell

    ​

    ​

    ​

    ​

    ​

    /s/ F. ANN MILLNER

    ​

    Director

    F. Ann Millner

    ​

    ​

    ​

    ​

    ​

    /s/ SILVIA M. PEREZ

    ​

    Director

    Silvia M. Perez

    ​

    ​

    ​

    ​

    ​

    /s/ LYNNE N. WARD

    ​

    Director

    Lynne N. Ward

    ​

    ​

    ​


    Get the next $MMSI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MMSI

    DatePrice TargetRatingAnalyst
    2/6/2026$107.00Buy
    BTIG Research
    3/28/2025$120.00Overweight
    Analyst
    12/11/2024$103.00 → $120.00Equal Weight → Overweight
    Wells Fargo
    6/28/2024$96.00Outperform
    Robert W. Baird
    4/11/2024$88.00Buy
    CL King
    2/7/2024$87.00Neutral
    BofA Securities
    12/21/2023$100.00Hold → Buy
    Canaccord Genuity
    12/20/2022$73.00 → $72.00Buy → Hold
    Canaccord Genuity
    More analyst ratings

    $MMSI
    SEC Filings

    View All

    Merit Medical Systems Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)

    1/8/26 4:33:36 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Systems Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)

    11/13/25 5:14:59 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Systems Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - MERIT MEDICAL SYSTEMS INC (0000856982) (Filer)

    11/3/25 5:24:14 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BTIG Research initiated coverage on Merit Medical with a new price target

    BTIG Research initiated coverage of Merit Medical with a rating of Buy and set a new price target of $107.00

    2/6/26 7:51:56 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Analyst initiated coverage on Merit Medical with a new price target

    Analyst initiated coverage of Merit Medical with a rating of Overweight and set a new price target of $120.00

    3/28/25 8:20:21 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Merit Medical from Equal Weight to Overweight and set a new price target of $120.00 from $103.00 previously

    12/11/24 7:56:29 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

    SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann Millner, Ed.D., formerly Merit's Lead Independent Director, as Chair of the Board effective January 5, 2026. Dr. Millner has served as a director of Merit since 2015 and as the Lead Independent Director since July 2021. She previously served as the Chair of Merit's Governance and Sustainability Committee. Dr. Millner currently serves as a member of the Utah State Senate, to which she was elected in 2015. She served as the President of Weber State University from 2002 through 2012

    1/8/26 4:05:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical to Participate at the J.P. Morgan Healthcare Conference

    SOUTH JORDAN, Utah, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader in healthcare technology, today announced that management will participate in the 44th Annual J.P. Morgan Healthcare Conference, which is being held at The Westin St. Francis Hotel in San Francisco, California, January 12-15, 2026. To learn more, visit Healthcare Conference. Martha G. Aronson, President and Chief Executive Officer, and Raul Parra, Chief Financial Officer, will present a company overview and update on Tuesday, January 13th at 4:30 pm Pacific Time / 7:30 pm Eastern Time. Presentation materials for the conference will be posted to Merit's investor relations websi

    12/23/25 9:00:00 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Provides Update on U.S. Reimbursement and Commercial Strategies for WRAPSODY® Cell-Impermeable Endoprosthesis

    SOUTH JORDAN, Utah, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, announced today that the U.S. Centers for Medicare & Medicaid Services ("CMS") has notified Merit that its application for Transitional Pass-Through ("TPT") incremental payment for WRAPSODY® Cell-Impermeable Endoprosthesis ("CIE") procedures in the outpatient and ambulatory surgery center ("ASC") settings requires further consideration prior to CMS making a final decision. CMS notified Merit that it has deferred Merit's application for the WRAPSODY® CIE to the Calendar Year 2027 Outpatient Prospective Payment System rule, making January 1, 2027, the ear

    11/13/25 4:05:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF OPERATING OFFICER Peterson Neil W. exercised 5,000 shares at a strike of $54.40 and sold $450,000 worth of shares (5,000 units at $90.00) (SEC Form 4)

    4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)

    1/8/26 12:57:30 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Executive Chairman Lampropoulos Fred P. sold $880,377 worth of shares (10,000 units at $88.04), decreasing direct ownership by 0.97% to 1,019,955 units (SEC Form 4)

    4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)

    11/26/25 3:22:04 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Executive Chairman Lampropoulos Fred P. sold $2,182,750 worth of shares (25,000 units at $87.31), decreasing direct ownership by 2% to 1,029,955 units (SEC Form 4)

    4 - MERIT MEDICAL SYSTEMS INC (0000856982) (Issuer)

    11/24/25 6:00:32 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 14, 2024 - FDA Roundup: June 14, 2024

    For Immediate Release: June 14, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued a proposed exemption for certain cottage cheese products from the requirements of the Food Traceability Rule. The proposal would exempt Grade “A” cottage cheese that appears on the Interstate Milk Shippers List from the requirements of the r

    6/14/24 3:54:45 PM ET
    $MMSI
    $BMY
    Medical/Dental Instruments
    Health Care
    Biotechnology: Pharmaceutical Preparations

    $MMSI
    Leadership Updates

    Live Leadership Updates

    View All

    Merit Medical Announces Resignation of President, Joseph Wright

    SOUTH JORDAN, Utah, Dec. 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) ("Merit" or the "Company"), a global leader of healthcare technology, today announced the resignation of its President, Joseph C. Wright, effective January 3, 2025. The Company noted that prior to Mr. Wright's resignation, Merit had received notice of allegations regarding his conduct, which Merit's independent directors investigated with the assistance of independent counsel. The allegations were unrelated to Merit's operations or financial performance. Based upon Mr. Wright's resignation, Merit's Board of Directors has re-appointed Fred P. Lampropoulos as Merit's President. ABOUT MERI

    12/16/24 4:00:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Shareholders Elect Silvia M. Perez as New Director

    SOUTH JORDAN, Utah, May 16, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced that its shareholders elected Silvia M. Perez, President of the Commercial Branding and Transportation Division at 3M Company, as a director in Merit's Annual Meeting of Shareholders held on May 15, 2024. Merit's shareholders also re-elected Fred P. Lampropoulos and Stephen C. Evans as directors. Ms. Perez and Messrs. Lampropoulos and Evans were elected to serve three-year terms. "We are pleased to welcome Silvia Perez as our newest director," said Mr. Lampropoulos, Merit's Chairman and Chief Executive Officer. "Her expertise and proven

    5/16/24 4:05:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Executive Leadership Team Update

    Joe Wright Appointed President Expands Deep Bench of Leadership Team Talent; Supports "Continued Growth Initiatives" Program SOUTH JORDAN, Utah, May 15, 2024 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader of healthcare technology, today announced the appointment of Joe Wright as President, effective immediately. As President, Mr. Wright will be responsible for the oversight of Merit's global commercial, marketing, and manufacturing operations. Mr. Wright has been an instrumental part of the Merit team over the past 19 years. He most recently served as Chief Commercial Officer, where he led the development and expansion of Merit's global commercial activit

    5/15/24 4:05:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Merit Medical Systems Inc.

    SC 13G/A - MERIT MEDICAL SYSTEMS INC (0000856982) (Subject)

    11/14/24 11:05:03 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Merit Medical Systems Inc. (Amendment)

    SC 13G/A - MERIT MEDICAL SYSTEMS INC (0000856982) (Subject)

    2/13/24 5:09:38 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Merit Medical Systems Inc. (Amendment)

    SC 13G/A - MERIT MEDICAL SYSTEMS INC (0000856982) (Subject)

    2/12/24 5:32:43 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    $MMSI
    Financials

    Live finance-specific insights

    View All

    Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025

    SOUTH JORDAN, Utah, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a global leader in healthcare technology, today announced that its Board of Directors unanimously appointed F. Ann Millner, Ed.D., formerly Merit's Lead Independent Director, as Chair of the Board effective January 5, 2026. Dr. Millner has served as a director of Merit since 2015 and as the Lead Independent Director since July 2021. She previously served as the Chair of Merit's Governance and Sustainability Committee. Dr. Millner currently serves as a member of the Utah State Senate, to which she was elected in 2015. She served as the President of Weber State University from 2002 through 2012

    1/8/26 4:05:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Reports Third Quarter 2025 Results and Updates Full-Year Guidance

    Highlights† Reported revenue of $384.2 million, up 13.0%Constant currency revenue* and constant currency revenue, organic* up 12.5% and up 7.8%, respectivelyGAAP operating margin of 11.1%, compared to 11.0% in prior year periodNon-GAAP operating margin* of 19.7%, compared to 19.2% in prior year periodGAAP EPS $0.46, down 3.0%Non-GAAP EPS* $0.92, up 6.7%Free cash flow* generation of $141.6 million over first nine months of 2025, up 17.6% year-over-year † Comparisons above are calculated for the current quarter compared with the third quarter of 2024, unless otherwise specified. Amounts stated in this release are rounded, while percentages are calculated from the underlying amounts. * Const

    10/30/25 4:05:00 PM ET
    $MMSI
    Medical/Dental Instruments
    Health Care

    Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025

    SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2025, after the close of the stock market on Thursday, October 30, 2025. Merit plans to hold its investor conference call on the same day (Thursday, October 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific). To access the conference call, please pre-register using the following link. Registrants will receive confirmation with dial-in details. A live webcast and slide deck can be accessed

    10/3/25 9:25:00 AM ET
    $MMSI
    Medical/Dental Instruments
    Health Care